TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.04E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.66E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.82E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 2.54E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair